Linked Data API

Show Search Form

Search Results

1135044
star this property registered interest false more like this
star this property date less than 2019-06-26more like thismore than 2019-06-26
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Spinal Muscular Atrophy: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, for what reason the announcement by NICE on 15 May 2019 that it would facilitate access by people with spinal muscular atrophy to a new drug for prescription on the NHS was followed several weeks later by an announcement that the drug would be available only to a specific group of those people; and if he will make a statement. more like this
star this property tabling member constituency Christchurch more like this
star this property tabling member printed
Sir Christopher Chope remove filter
star this property uin 269611 remove filter
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-01more like thismore than 2019-07-01
star this property answer text <p>The National Institute for Health and Care Excellence (NICE) has advised that on 15 May 2019 it confirmed that it was able to recommend nusinersen for the treatment of spinal muscular atrophy. In the announcement, NICE said the treatment would be made available under the terms of the managed access agreement between NHS England and NHS Improvement and Biogen. However, the full detail of the agreement was not given in the announcement and NICE accepts this was misleading for some of the patient population. NICE provided clarification at the earliest opportunity and has apologised to individuals affected.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-01T15:53:48.517Zmore like thismore than 2019-07-01T15:53:48.517Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
242
unstar this property label Biography information for Sir Christopher Chope more like this